Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 15, 2000New England Journal of Medicine

Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

HKH KöhlerUniversidad de Santiago de ChilePGPeter J. GrantGeneral / Preventive / Lipids

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Köhler et al. (2000) studied this question.

synapsesocial.com/papers/6a707a51fe4101aa97e02f13https://doi.org/10.1056/nejm200006153422406
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Haemostatic variables associated with diabetes and its complications.1979 · 288 citations
  2. 2An updated coronary risk profile. A statement for health professionals.1991 · 1,857 citations
  3. 3Binding of Tissue-Plasminogen Activator to Fibrin: Effect of Ultrasound1998 · 120 citations
  4. 4Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin1989 · 292 citations
  5. 5Association of a Common Polymorphism in the Factor XIII Gene With Venous Thrombosis1999 · 188 citations